Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.061 AUD | +1.67% | +1.67% | -14.08% |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.08% | 11.57M | |
-2.86% | 87.31B | |
+2.63% | 40.86B | |
-21.49% | 29.36B | |
+58.56% | 24.49B | |
-13.93% | 17.31B | |
-18.55% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Advances to the Efficacy Portion of its Phase 2 Prostate Cancer Trial